Posttransplant Lymphoproliferative Disorders and Immunodeficiency

Alla Keyzner; Douglas Tremblay; Julie Teruya-Feldstein

doi:10.1016/B978-0-323-56738-1.00016-6

Posttransplant Lymphoproliferative Disorders and Immunodeficiency

Alla Keyzner, Douglas Tremblay, Julie Teruya-Feldstein

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Cell-based medicine has seen transformative change over the past decades with bone marrow, umbilical cord, solid organ, and fecal transplantation combined with traditional multiagent chemotherapy, immunotherapy, and maintenance regimens with excellent response and/or subsequent sequelae, a range of pathology, and molecular monitoring. The range of pathology includes reactive hyperplasia, polymorphous to monomorphic proliferations with polyclonal, oligoclonal, and clonal changes that can be tracked by a range of techniques for minimal residual disease.

Original language	English
Title of host publication	Atlas of Diagnostic Hematology
Publisher	Elsevier
Pages	322-338
Number of pages	17
ISBN (Electronic)	9780323567381
ISBN (Print)	9780323567343
DOIs	https://doi.org/10.1016/B978-0-323-56738-1.00016-6
State	Published - 1 Jan 2020

Keywords

bone marrow transplantation
cell-based medicine
cytogenomics
fluorescence in situ hybridization (FISH)
graft-versus-host disease
karyotype
molecular
molecular genetics
pathology
posttransplant lymphoproliferative disorders (PTLD)
transplantation

Access to Document

10.1016/B978-0-323-56738-1.00016-6

Cite this

@inbook{79a3d45425a34fb5b466627411a23b30,

title = "Posttransplant Lymphoproliferative Disorders and Immunodeficiency",

abstract = "Cell-based medicine has seen transformative change over the past decades with bone marrow, umbilical cord, solid organ, and fecal transplantation combined with traditional multiagent chemotherapy, immunotherapy, and maintenance regimens with excellent response and/or subsequent sequelae, a range of pathology, and molecular monitoring. The range of pathology includes reactive hyperplasia, polymorphous to monomorphic proliferations with polyclonal, oligoclonal, and clonal changes that can be tracked by a range of techniques for minimal residual disease.",

keywords = "bone marrow transplantation, cell-based medicine, cytogenomics, fluorescence in situ hybridization (FISH), graft-versus-host disease, karyotype, molecular, molecular genetics, pathology, posttransplant lymphoproliferative disorders (PTLD), transplantation",

author = "Alla Keyzner and Douglas Tremblay and Julie Teruya-Feldstein",

year = "2020",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-56738-1.00016-6",

language = "English",

isbn = "9780323567343",

pages = "322--338",

booktitle = "Atlas of Diagnostic Hematology",

publisher = "Elsevier",

address = "Netherlands",

}

TY - CHAP

T1 - Posttransplant Lymphoproliferative Disorders and Immunodeficiency

AU - Keyzner, Alla

AU - Tremblay, Douglas

AU - Teruya-Feldstein, Julie

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Cell-based medicine has seen transformative change over the past decades with bone marrow, umbilical cord, solid organ, and fecal transplantation combined with traditional multiagent chemotherapy, immunotherapy, and maintenance regimens with excellent response and/or subsequent sequelae, a range of pathology, and molecular monitoring. The range of pathology includes reactive hyperplasia, polymorphous to monomorphic proliferations with polyclonal, oligoclonal, and clonal changes that can be tracked by a range of techniques for minimal residual disease.

AB - Cell-based medicine has seen transformative change over the past decades with bone marrow, umbilical cord, solid organ, and fecal transplantation combined with traditional multiagent chemotherapy, immunotherapy, and maintenance regimens with excellent response and/or subsequent sequelae, a range of pathology, and molecular monitoring. The range of pathology includes reactive hyperplasia, polymorphous to monomorphic proliferations with polyclonal, oligoclonal, and clonal changes that can be tracked by a range of techniques for minimal residual disease.

KW - bone marrow transplantation

KW - cell-based medicine

KW - cytogenomics

KW - fluorescence in situ hybridization (FISH)

KW - graft-versus-host disease

KW - karyotype

KW - molecular

KW - molecular genetics

KW - pathology

KW - posttransplant lymphoproliferative disorders (PTLD)

KW - transplantation

UR - http://www.scopus.com/inward/record.url?scp=85167747033&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-56738-1.00016-6

DO - 10.1016/B978-0-323-56738-1.00016-6

M3 - Chapter

AN - SCOPUS:85167747033

SN - 9780323567343

SP - 322

EP - 338

BT - Atlas of Diagnostic Hematology

PB - Elsevier

ER -

Posttransplant Lymphoproliferative Disorders and Immunodeficiency

Abstract

Keywords

Access to Document

Fingerprint

Cite this